← Open Payments lookup

OYENIKE OGUNMEKAN: Open Payments

NPI 1154914554 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$434 in 22 payments from 9 companies in 2025. Trend: 2023 $1,114 · 2024 $560 · 2025 $434

Food & beverage: $434
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$101
ABBVIE INC.4$75
Axsome Therapeutics, Inc.4$74
E.R. Squibb & Sons, L.L.C.3$51
Janssen Pharmaceuticals, Inc1$31
Otsuka America Pharmaceutical, Inc.2$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$28
Teva Pharmaceuticals USA, Inc.1$25
Vanda Pharmaceuticals Inc.1$18

Products named: INGREZZA, VRAYLAR, Auvelity, COBENFY, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR, FANAPT.

Industry payments across TX — which companies pay providers there.